
Fever, C-Reactive Protein, and Other Acute-Phase Reactants During Treatment of Infective Endocarditis
Lars Olaison, MD, PhD;
Harriet Hogevik, MD, PhD;
Kjell Alestig, MD, PhD
Arch Intern Med. 1997;157(8):885-892.
Abstract
 |  |
Background Fever and sustained elevations of levels of C-reactive protein, erythrocyte sedimentation rate, and other inflammatory markers are common problems during treatment of infective endocarditis. We studied the value of these measurements during an 8-year period in all episodes of infective endocarditis treated in 1 university-affiliated institution.
Methods A total of 193 consecutive episodes that fulfilled the criteria for infective endocarditis were prospectively enrolled during 2 periods, 1984 through 1988 and 1993 through 1995. Fever and results of serial measurements of C-reactive protein, erythrocyte sedimentation rate, white blood cell counts, and platelet counts were related to the clinical course of infective endocarditis.
Results Fever persisted or recurred in 108 episodes (57%) despite appropriate antibiotic treatment. The causes of persistent fever and recurrent fever were different. Persistent fever that lasted 7 days or longer was caused by a
complicating cardiac infection in 56% of these episodes. Recurrent fever, noted in 31% of all episodes and the major cause of fever during the third and fourth treatment weeks, was caused most often by hypersensitivity reactions to β-lactams. Elevations in C-reactive protein levels were significantly prolonged in the episodes with complicated courses compared with the episodes with uncomplicated courses, while mean erythrocyte sedimentation rate remained unchanged during treatment, not differentiating between complicated and uncomplicated episodes.
Conclusions Fever during treatment must be analyzed in terms of persistence and recurrence to provide a basis for clinical decisions. Serial measurements of Creactive protein are useful to monitor the reponse to antimicrobial therapy and to detect complications, while serial determinations of erythrocyte sedimentation rate are of no value.
Arch Intern Med. 1997;157:885-892
Author Affiliations
From the Department of Infectious Diseases, Göteborg University, Göteborg, Sweden.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Lipopolysaccharide-Binding Protein: A New Biomarker for Infectious Endocarditis?
Vollmer et al.
Clin. Chem. 2009;55:295-304.
ABSTRACT
| FULL TEXT
Prognostic Value of Serial C-Reactive Protein Measurements in Left-Sided Native Valve Endocarditis
Verhagen et al.
Arch Intern Med 2008;168:302-307.
ABSTRACT
| FULL TEXT
Antimicrobial treatment of infective endocarditis caused by viridans streptococci highly susceptible to penicillin: historic overview and future considerations
Verhagen et al.
J Antimicrob Chemother 2006;57:819-824.
ABSTRACT
| FULL TEXT
Utility of serum C-reactive protein in assessing the outcome of infective endocarditis
Heiro et al.
Eur Heart J 2005;26:1873-1881.
ABSTRACT
| FULL TEXT
Incidence of {beta}-Lactam-Induced Delayed Hypersensitivity and Neutropenia During Treatment of Infective Endocarditis
Olaison et al.
Arch Intern Med 1999;159:607-615.
ABSTRACT
| FULL TEXT
C-Reactive Protein—Undervalued, Underutilized
Gambino
Clin. Chem. 1997;43:2017-2018.
FULL TEXT
|